HYUNDAI BIOLAND Co.,Ltd. Statistics
Total Valuation
HYUNDAI BIOLAND Co.,Ltd. has a market cap or net worth of KRW 123.00 billion. The enterprise value is 136.11 billion.
Market Cap | 123.00B |
Enterprise Value | 136.11B |
Important Dates
The next estimated earnings date is Tuesday, February 4, 2025.
Earnings Date | Feb 4, 2025 |
Ex-Dividend Date | Dec 27, 2024 |
Share Statistics
HYUNDAI BIOLAND Co.,Ltd. has 30.00 million shares outstanding. The number of shares has increased by 120.00% in one year.
Current Share Class | n/a |
Shares Outstanding | 30.00M |
Shares Change (YoY) | +120.00% |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | 1.76% |
Float | 19.50M |
Valuation Ratios
The trailing PE ratio is 21.81 and the forward PE ratio is 9.81.
PE Ratio | 21.81 |
Forward PE | 9.81 |
PS Ratio | 1.40 |
PB Ratio | 0.85 |
P/TBV Ratio | 0.92 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.57, with an EV/FCF ratio of -105.94.
EV / Earnings | 17.55 |
EV / Sales | 1.12 |
EV / EBITDA | 7.57 |
EV / EBIT | 11.91 |
EV / FCF | -105.94 |
Financial Position
The company has a current ratio of 1.93, with a Debt / Equity ratio of 0.23.
Current Ratio | 1.93 |
Quick Ratio | 0.87 |
Debt / Equity | 0.23 |
Debt / EBITDA | 1.88 |
Debt / FCF | -26.26 |
Interest Coverage | 7.41 |
Financial Efficiency
Return on equity (ROE) is 5.46% and return on invested capital (ROIC) is 4.06%.
Return on Equity (ROE) | 5.46% |
Return on Assets (ROA) | 3.80% |
Return on Capital (ROIC) | 4.06% |
Revenue Per Employee | 378.65M |
Profits Per Employee | 24.24M |
Employee Count | 320 |
Asset Turnover | 0.64 |
Inventory Turnover | 1.79 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -57.15% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -57.15% |
50-Day Moving Average | 4,644.90 |
200-Day Moving Average | 6,128.75 |
Relative Strength Index (RSI) | 39.15 |
Average Volume (20 Days) | 120,497 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HYUNDAI BIOLAND Co.,Ltd. had revenue of KRW 121.17 billion and earned 7.76 billion in profits. Earnings per share was 188.03.
Revenue | 121.17B |
Gross Profit | 48.09B |
Operating Income | 11.43B |
Pretax Income | 10.11B |
Net Income | 7.76B |
EBITDA | 17.99B |
EBIT | 11.43B |
Earnings Per Share (EPS) | 188.03 |
Balance Sheet
The company has 20.62 billion in cash and 33.73 billion in debt, giving a net cash position of -13.11 billion or -436.90 per share.
Cash & Cash Equivalents | 20.62B |
Total Debt | 33.73B |
Net Cash | -13.11B |
Net Cash Per Share | -436.90 |
Equity (Book Value) | 144.99B |
Book Value Per Share | 4,832.93 |
Working Capital | 43.24B |
Cash Flow
In the last 12 months, operating cash flow was 1.85 billion and capital expenditures -3.13 billion, giving a free cash flow of -1.28 billion.
Operating Cash Flow | 1.85B |
Capital Expenditures | -3.13B |
Free Cash Flow | -1.28B |
FCF Per Share | -42.82 |
Margins
Gross margin is 39.69%, with operating and profit margins of 9.44% and 6.40%.
Gross Margin | 39.69% |
Operating Margin | 9.44% |
Pretax Margin | 8.35% |
Profit Margin | 6.40% |
EBITDA Margin | 14.85% |
EBIT Margin | 9.44% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 35.00, which amounts to a dividend yield of 0.85%.
Dividend Per Share | 35.00 |
Dividend Yield | 0.85% |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | 13.54% |
Buyback Yield | -120.00% |
Shareholder Yield | -119.15% |
Earnings Yield | 4.59% |
FCF Yield | -1.04% |
Stock Splits
The last stock split was on May 17, 2024. It was a forward split with a ratio of 2.
Last Split Date | May 17, 2024 |
Split Type | Forward |
Split Ratio | 2 |
Scores
HYUNDAI BIOLAND Co.,Ltd. has an Altman Z-Score of 3.85.
Altman Z-Score | 3.85 |
Piotroski F-Score | n/a |